BackAstria Therapeutics Overview

Astria Therapeutics Research & Development

Research & Development expenses for ATXS.

Quarterly R&D Expenses

$24.15M
↑ 17.74% YoY

As of Sep 30, 2025

Annual R&D Expenses (TTM)

$98.04M
↑ 42.89% YoY

Trailing 12 months ending Sep 30, 2025

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin